F. ;. Paris, P. Ap-hp, ;. Hospital, . Inserm-u1088, J. V. Ufr-de-médecine-et-pharmacie et al., Centre de Recherche des Cordeliers, Paris 06, France. 10 Institute of Cardiometabolism and Nutrition ICAN, 11 Department of Pharmacology and CIC-1421, AP-HP, AP-HP, Pitié-Salpêtrière Hospital, vol.12

D. G. Armstrong, L. A. Lavery, and L. B. Harkless, Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation, Diabetes Care, vol.21, pp.855-864, 1998.

R. J. Guzman, D. M. Brinkley, P. M. Schumacher, R. M. Donahue, H. Beavers et al., Tibial artery calcification as a marker of amputation risk in patients with peripheral arterial disease, J Am Coll Cardiol, vol.51, pp.1967-74, 2008.

O. Bourron, C. E. Aubert, and S. Liabeuf, Below-knee arterial calcification in type 2 diabetes: association with receptor activator of nuclear factor kappaB ligand, osteoprotegerin, and neuropathy, J Clin Endocrinol Metab, vol.99, pp.4250-4258, 2014.

B. J. Goldstein and R. Scalia, Adiponectin: a novel adipokine linking adipocytes and vascular function, J Clin Endocrinol Metab, vol.89, pp.2563-2571, 2004.

X. H. Luo, L. L. Zhao, L. Q. Yuan, M. Wang, H. Xie et al., Development of arterial calcification in adiponectin-deficient mice: adiponectin regulates arterial calcification, J Bone Miner Res, vol.24, pp.1461-1469, 2009.

Y. Lu, Y. Bian, Y. Wang, R. Bai, J. Wang et al., Globular adiponectin reduces vascular calcification via inhibition of ER-stress-mediated smooth muscle cell apoptosis, Int J Clin Exp Pathol, vol.8, pp.2545-54, 2015.

T. Kadowaki, T. Yamauchi, N. Kubota, K. Hara, K. Ueki et al., Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome, J Clin Invest, vol.116, pp.1784-92, 2006.

C. A. Abbott, A. L. Carrington, and H. Ashe, The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort, Diabet Med, vol.19, pp.377-84, 2002.

A. S. Agatston, W. R. Janowitz, F. J. Hildner, N. R. Zusmer, M. Viamonte et al., Quantification of coronary artery calcium using ultrafast computed tomography, J Am Coll Cardiol, vol.15, pp.827-859, 1990.

P. Stenvinkel, K. Luttropp, and D. Mcguinness, CDKN2A/p16INK4a expression is associated with vascular progeria in chronic kidney disease, Aging, vol.9, pp.494-507, 2017.

A. Mary, A. Hartemann, and M. Brazier, Higher parathyroid hormone levels are associated with increased below-the-knee arterial calcification in type 2 diabetes, Diabetes Metab, vol.44, pp.305-313, 2018.

A. Mary, A. Hartemann, and S. Liabeuf, Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients, Cardiovasc Diabetol, vol.16, p.24, 2017.

D. A. Towler, Commonalities between vasculature and bone: an osseocentric view of arteriosclerosis, Circulation, vol.135, pp.320-322, 2017.

M. Cnop, P. J. Havel, and K. M. Utzschneider, Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex, Diabetologia, vol.46, pp.459-69, 2003.

N. Katsiki, C. Mantzoros, and D. P. Mikhailidis, Adiponectin, lipids and atherosclerosis, Curr Opin Lipidol, vol.28, pp.347-54, 2017.

M. Ruscica, L. Steffani, and P. Magni, Adiponectin interactions in bone and cartilage biology and disease, Vitam Horm, vol.90, pp.321-360, 2012.

A. J. Rodriguez, N. Vdos, S. Mastronardi, C. A. Neeman, T. Paz-filho et al., Association between circulating adipocytokine concentrations and microvascular complications in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of controlled cross-sectional studies, J Diabetes Complications, vol.30, pp.357-67, 2016.

J. K. Zhan, Y. J. Wang, and Y. Wang, Adiponectin attenuates the osteoblastic differentiation of vascular smooth muscle cells through the AMPK/mTOR pathway, Exp Cell Res, vol.323, pp.352-360, 2014.

D. M. Maahs, L. G. Ogden, and G. L. Kinney, Low plasma adiponectin levels predict progression of coronary artery calcification, Circulation, vol.111, pp.747-53, 2005.

N. K. Lee, H. Sowa, and E. Hinoi, Endocrine regulation of energy metabolism by the skeleton, Cell, vol.130, pp.456-69, 2007.

S. Lindberg, S. H. Pedersen, and R. Mogelvang, Usefulness of adiponectin as a predictor of all cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention, Am J Cardiol, vol.109, pp.492-498, 2012.

T. Ohara, K. Hashimura, and M. Asakura, Dynamic changes in plasma total and high molecular weight adiponectin levels in acute heart failure, J Cardiol, vol.58, pp.181-90, 2011.

B. Dieplinger, A. Gegenhuber, W. Poelz, M. Haltmayer, and T. Mueller, Prognostic value of increased adiponectin plasma concentrations in patients with acute destabilized heart failure, Clin Biochem, vol.42, pp.1190-1193, 2009.

J. M. Dekker, T. Funahashi, and G. Nijpels, Prognostic value of adiponectin for cardiovascular disease and mortality, J Clin Endocrinol Metab, vol.93, pp.1489-96, 2008.

R. Schnabel, C. M. Messow, and E. Lubos, Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study, Eur Heart J, vol.29, pp.649-57, 2008.